Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Vildagliptine and Glimepiride on Glucose Variability

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hye Seung Jung, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01812122
First received: March 13, 2013
Last updated: November 19, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)